Cellaven is a French biotechnology company developing flexible automation solutions for cell culture. As advanced therapies move from early research towards more standardized and scalable processes, cell culture reproducibility and workflow automation become increasingly critical. Cellaven has developed Nestor, a compact automation system designed to automate medium changes while allowing researchers to maintain their existing cell culture protocols and consumables. Its flexible architecture supports a wide range of culture formats and applications, including primary cells, iPSCs, organoids, and adherent or suspension cultures. By automating repetitive feeding steps, Nestor helps research teams reduce hands-on time and manual interventions, standardize culture conditions, and improve workflow reproducibility, particularly for long-term and demanding cell culture protocols. Cellaven’s ambition is to bridge the gap between manual cell culture and fully automated platforms, making automation accessible from the R&D and process development stages of advanced therapy development.
